GlassScriptPhysician profile
Ashley Y Williams
NPI 1740674720
$1,555.03
in general payments reported to CMS, 2019-2025
22 companies · $94.97 in 2025
The $94.97 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $16.67 · 2021: $326 · 2022: $378 · 2023: $341 · 2024: $257 · 2025: $94.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $556 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.25 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $284.74 | 2021-2022 | |
| Depuy Synthes Sales INC. | $200.75 | 2021-2022 | |
| Medical Device Business Services, INC. | $137.01 | 2023 | |
| Kerecis Limited | $126.40 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Biogen, INC. | $123.07 | 2019 | |
| Aroa Biosurgery Incorporated | $101.39 | 2022-2025 | |
| Abbott Laboratories | $87.50 | 2022 | |
| Polynovo North America LLC | $86.22 | 2022-2023 | |
| Baxter Healthcare | $73.36 | 2021-2025 | Recothrom, Tisseel |
| Intuitive Surgical, INC. | $47.31 | 2024 | |
| Kci USA, INC. | $37.42 | 2021-2023 | Promogran Prisma |
| Merck Sharp & Dohme LLC | $36.94 | 2022-2024 | Recarbrio, Zerbaxa, Dificid |
| Davol INC. | $32.51 | 2024 | Phasix Mesh |
| Inspire Medical Systems, INC. | $29.73 | 2024 | Inspire |
| Astrazeneca Pharmaceuticals LP | $27.03 | 2023-2024 | Andexxa |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $20.35 | 2023 | Gattex |
| Novo Nordisk INC | $19.99 | 2023 | Ozempic |
| Mallinckrodt Hospital Products INC. | $18.90 | 2023 | Inomax |
| Pacira Pharmaceuticals Incorporated | $18.47 | 2019 | |
| Allergan, INC. | $16.67 | 2020 | |
| Smith+Nephew, INC. | $15.41 | 2024 | Acticoat 4" X 4", Versajet, Collagenase Santyl |
| Avanos Medical | $13.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.